MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CLDX — Celldex Therapeutics, Inc
NasdaqCelldex Therapeutics, Inc
$31.65
-0.53(-1.65%)
- O
- 32.26
- H
- 32.54
- L
- 30.98
- V
- 2.36M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CLDX
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
SectorNot available
IPO DateMay 15, 1986
Employees198
Stock ExchangeNasdaq
Ticker SymbolCLDX
Websitehttps://www.celldex.com
Key Financial Statistics
| Market Cap | $2.44B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $22.10 - $45.14 |
| 52-Week Avg Volume | 1.00M |
| VWAP | $31.66 |
| Transactions | 18,547 |
| Total Recorded Bars | 10,174 days |